LGND

Ligand Pharma

295.00

+1.74+0.59%

After Hours: 295.00 0.00 0.00%19:30 10/08 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE290.41/293.26

TODAY RANGE281.74-296.48

VOL318.88K

MARKET CAP5.88B

52 WEEK RANGE175.89-326.63

AVG VOL (3M)258.66K

% TURNOVER1.43%

TURNOVER--

P/E (TTM)31.38

% RANGE5.03%

EPS(TTM)9.40

P/E(FORWARD)56.47

P/B6.07

BVPS48.57

DIVIDEND--

P/S27.13

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP5.74B

SHARES OUTSTANDING19.94M

NEXT EARNINGS11/04-11/09

FREE FLOAT19.47M

LOT SIZE1

EX-DATE11/02/2022

News

Press Releases

Financial Reports

Profile

Seeking Alpha·10/01 16:30
StoneX updates its best ideas list
Seeking Alpha·09/25 18:19
Ligand Pharma a new Outperform at Barclays on biopharma royalty aggregation
TipRanks·09/25 13:45
Twilio downgraded, Synopsys upgraded: Wall Street’s top analyst calls
Dow Jones·09/25 12:39
Ligand Pharmaceuticals Price Target Announced at $345.00/Share by Barclays
Dow Jones·09/25 12:39
Ligand Pharmaceuticals Initiated at Overweight by Barclays
TipRanks·09/25 08:50
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Natera (NTRA) and Aveanna Healthcare Holdings (AVAH)
TipRanks·09/25 08:45
Ligand initiated with an Overweight at Barclays
Seeking Alpha·09/24 17:17
Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies
Dow Jones·09/24 16:04
Ligand Pharmaceuticals Price Target Maintained With a $358.00/Share by HC Wainwright & Co.
TipRanks·09/24 15:10
Wainwright sees upside in Ligand after new CAR-T investment in AvenCell
TipRanks·09/24 13:43
Ligand Pharma Announces $47 Million AvenCell Financing Deal
NASDAQ·09/24 11:48
Ligand Commits Upto $47 Mln To AvenCell Cancer Cell Therapy
TipRanks·09/24 11:05
Ligand enters financing agreement with AvenCell for up to $47M
Dow Jones·09/24 11:00
Press Release: Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for Up to $47 Million
Dow Jones·09/23 15:23
Ligand Pharmaceuticals Is Maintained at Buy by Citigroup

Same Industry

Name/Symbol

Change%

Price

LGND

McKesson

MCK

-0.31%

866.64

Biogen Inc

BIIB

-1.62%

215.50

Amgen Inc

AMGN

+1.55%

385.65

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+7.67%

0.1249

Lilly Eli & Co

LLY

+1.04%

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

0.00%

2.030

Johnson & Johnson

JNJ

-0.09%

269.99

Abbvie Inc

ABBV

+0.35%

266.69

Zoetis Inc

ZTS

-0.74%

70.87

Gilead Sciences Inc

GILD

-0.52%

150.11

NVO

Bristol-Myers Squibb Co

BMY

+0.35%

63.06

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-2.10%

27.53

Sanofi FR

SNY

+0.42%

41.11

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.39%

140.37

Dr Reddys Labs

RDY

0.00%

12.19

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.